Baidu
map

Dement Geriatr Cogn Dis Extra:老年康复患者神经精神症状患病率高

2013-06-09 Dement Geriatr Cogn Dis Extra 医学论坛网

  近期Dement Geriatr Cogn Dis Extra网络版发表的一项多中心横断面研究的结果显示,在康复中心接受治疗的老年康复患者神经精神症状的患病率处于较高水平,但仍低于在门诊老年患者的患病率。   研究为确定神经精神症状在老年康复患者中的发病率,研究者对其中痴呆和非痴呆患者的神经精神症状进行了对比,并评估了患者认知损害严重程度与神经精神症状之间的联系。   2009年2月,研究

  近期Dement Geriatr Cogn Dis Extra网络版发表的一项多中心横断面研究的结果显示,在康复中心接受治疗的老年康复患者神经精神症状的患病率处于较高水平,但仍低于在门诊老年患者的患病率。

  研究为确定神经精神症状在老年康复患者中的发病率,研究者对其中痴呆和非痴呆患者的神经精神症状进行了对比,并评估了患者认知损害严重程度与神经精神症状之间的联系。

  2009年2月,研究者对在巴黎四家老年康复中心中接受治疗的年龄在75岁及以上的老人进行了研究,研究采用的12项精神神经量表项目及评估的四种亚综合征均经欧洲阿尔兹海默氏病协会审定。

  共194名患者参加研究,其中的149名(占参与者总数的78.6%)有痴呆症状,154名(占参与者总数的79.4%)在研究前一周至少出现过一种神经精神症状。痴呆组中最普遍的神经精神症状是焦虑不安(占该组人数的36.9%),非痴呆组中是抑郁(占该组人数的35.6%)。多动(P<0.001)和妄想(P=0.01)在痴呆组中的患病率显著高于非痴呆组。在痴呆组中认知损害的严重程度与多动(P=0.01)及精神疾病(P=0.02)有关。

Neuropsychiatric Symptoms in Elderly Inpatients: A Multicenter Cross-Sectional Study
Abstract
Background/Aims: We determined the prevalence of neuropsychiatric symptoms in geriatric rehabilitation patients to compare neuropsychiatric symptoms between patients with and without dementia, and to evaluate associations linking severity of cognitive impairment and neuropsychiatric symptoms. Methods: In February 2009, we studied patients aged 75 years or older who had been admitted to four geriatric rehabilitation units in the Paris area. The twelve Neuropsychiatric Inventory items and four neuropsychiatric subsyndromes defined by the European Alzheimer's Disease Consortium were evaluated. Results: Of the 194 patients, 149 (76.8%) had dementia, and 154 (79.4%) had exhibited at least one neuropsychiatric symptom during the past week. Agitation was the most common neuropsychiatric symptom in the group with dementia (36.9%) and depression in the group without dementia (35.6%). The dementia group had significantly higher prevalences of hyperactivity (p < 0.001) and delusions (p = 0.01) than the non-dementia group. In the dementia group, severity of cognitive impairment was associated with hyperactivity (p = 0.01) and psychosis (p = 0.02). Conclusion: The prevalence of neuropsychiatric symptoms among geriatric rehabilitation patients was high but not higher than in elderly outpatients.

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=2011823, encodeId=51e7201182370, content=<a href='/topic/show?id=7d69598468' target=_blank style='color:#2F92EE;'>#Dis#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=96, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5984, encryptionId=7d69598468, topicName=Dis)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c689267, createdName=cmj8wellington, createdTime=Wed Apr 02 23:11:00 CST 2014, time=2014-04-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1656580, encodeId=56ec1656580fa, content=<a href='/topic/show?id=3ca31e71903' target=_blank style='color:#2F92EE;'>#TRA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17719, encryptionId=3ca31e71903, topicName=TRA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=757b24868428, createdName=bsmagic9140, createdTime=Sun Mar 09 21:11:00 CST 2014, time=2014-03-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2032032, encodeId=598a2032032c2, content=<a href='/topic/show?id=07c4e6558d5' target=_blank style='color:#2F92EE;'>#精神症状#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=76558, encryptionId=07c4e6558d5, topicName=精神症状)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e87531, createdName=klivis, createdTime=Sat Dec 28 19:11:00 CST 2013, time=2013-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2021463, encodeId=465e2021463bd, content=<a href='/topic/show?id=31e8e9669d' target=_blank style='color:#2F92EE;'>#GER#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7966, encryptionId=31e8e9669d, topicName=GER)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=48732500158, createdName=12498c32m68暂无昵称, createdTime=Mon Sep 23 06:11:00 CST 2013, time=2013-09-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1250386, encodeId=cb411250386a8, content=<a href='/topic/show?id=7d6f52988e1' target=_blank style='color:#2F92EE;'>#患病率#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=52988, encryptionId=7d6f52988e1, topicName=患病率)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f49517, createdName=xinmeili, createdTime=Tue Jun 11 00:11:00 CST 2013, time=2013-06-11, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=2011823, encodeId=51e7201182370, content=<a href='/topic/show?id=7d69598468' target=_blank style='color:#2F92EE;'>#Dis#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=96, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5984, encryptionId=7d69598468, topicName=Dis)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c689267, createdName=cmj8wellington, createdTime=Wed Apr 02 23:11:00 CST 2014, time=2014-04-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1656580, encodeId=56ec1656580fa, content=<a href='/topic/show?id=3ca31e71903' target=_blank style='color:#2F92EE;'>#TRA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17719, encryptionId=3ca31e71903, topicName=TRA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=757b24868428, createdName=bsmagic9140, createdTime=Sun Mar 09 21:11:00 CST 2014, time=2014-03-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2032032, encodeId=598a2032032c2, content=<a href='/topic/show?id=07c4e6558d5' target=_blank style='color:#2F92EE;'>#精神症状#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=76558, encryptionId=07c4e6558d5, topicName=精神症状)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e87531, createdName=klivis, createdTime=Sat Dec 28 19:11:00 CST 2013, time=2013-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2021463, encodeId=465e2021463bd, content=<a href='/topic/show?id=31e8e9669d' target=_blank style='color:#2F92EE;'>#GER#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7966, encryptionId=31e8e9669d, topicName=GER)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=48732500158, createdName=12498c32m68暂无昵称, createdTime=Mon Sep 23 06:11:00 CST 2013, time=2013-09-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1250386, encodeId=cb411250386a8, content=<a href='/topic/show?id=7d6f52988e1' target=_blank style='color:#2F92EE;'>#患病率#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=52988, encryptionId=7d6f52988e1, topicName=患病率)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f49517, createdName=xinmeili, createdTime=Tue Jun 11 00:11:00 CST 2013, time=2013-06-11, status=1, ipAttribution=)]
    2014-03-09 bsmagic9140
  3. [GetPortalCommentsPageByObjectIdResponse(id=2011823, encodeId=51e7201182370, content=<a href='/topic/show?id=7d69598468' target=_blank style='color:#2F92EE;'>#Dis#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=96, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5984, encryptionId=7d69598468, topicName=Dis)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c689267, createdName=cmj8wellington, createdTime=Wed Apr 02 23:11:00 CST 2014, time=2014-04-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1656580, encodeId=56ec1656580fa, content=<a href='/topic/show?id=3ca31e71903' target=_blank style='color:#2F92EE;'>#TRA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17719, encryptionId=3ca31e71903, topicName=TRA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=757b24868428, createdName=bsmagic9140, createdTime=Sun Mar 09 21:11:00 CST 2014, time=2014-03-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2032032, encodeId=598a2032032c2, content=<a href='/topic/show?id=07c4e6558d5' target=_blank style='color:#2F92EE;'>#精神症状#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=76558, encryptionId=07c4e6558d5, topicName=精神症状)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e87531, createdName=klivis, createdTime=Sat Dec 28 19:11:00 CST 2013, time=2013-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2021463, encodeId=465e2021463bd, content=<a href='/topic/show?id=31e8e9669d' target=_blank style='color:#2F92EE;'>#GER#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7966, encryptionId=31e8e9669d, topicName=GER)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=48732500158, createdName=12498c32m68暂无昵称, createdTime=Mon Sep 23 06:11:00 CST 2013, time=2013-09-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1250386, encodeId=cb411250386a8, content=<a href='/topic/show?id=7d6f52988e1' target=_blank style='color:#2F92EE;'>#患病率#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=52988, encryptionId=7d6f52988e1, topicName=患病率)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f49517, createdName=xinmeili, createdTime=Tue Jun 11 00:11:00 CST 2013, time=2013-06-11, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=2011823, encodeId=51e7201182370, content=<a href='/topic/show?id=7d69598468' target=_blank style='color:#2F92EE;'>#Dis#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=96, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5984, encryptionId=7d69598468, topicName=Dis)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c689267, createdName=cmj8wellington, createdTime=Wed Apr 02 23:11:00 CST 2014, time=2014-04-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1656580, encodeId=56ec1656580fa, content=<a href='/topic/show?id=3ca31e71903' target=_blank style='color:#2F92EE;'>#TRA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17719, encryptionId=3ca31e71903, topicName=TRA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=757b24868428, createdName=bsmagic9140, createdTime=Sun Mar 09 21:11:00 CST 2014, time=2014-03-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2032032, encodeId=598a2032032c2, content=<a href='/topic/show?id=07c4e6558d5' target=_blank style='color:#2F92EE;'>#精神症状#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=76558, encryptionId=07c4e6558d5, topicName=精神症状)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e87531, createdName=klivis, createdTime=Sat Dec 28 19:11:00 CST 2013, time=2013-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2021463, encodeId=465e2021463bd, content=<a href='/topic/show?id=31e8e9669d' target=_blank style='color:#2F92EE;'>#GER#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7966, encryptionId=31e8e9669d, topicName=GER)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=48732500158, createdName=12498c32m68暂无昵称, createdTime=Mon Sep 23 06:11:00 CST 2013, time=2013-09-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1250386, encodeId=cb411250386a8, content=<a href='/topic/show?id=7d6f52988e1' target=_blank style='color:#2F92EE;'>#患病率#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=52988, encryptionId=7d6f52988e1, topicName=患病率)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f49517, createdName=xinmeili, createdTime=Tue Jun 11 00:11:00 CST 2013, time=2013-06-11, status=1, ipAttribution=)]
  5. [GetPortalCommentsPageByObjectIdResponse(id=2011823, encodeId=51e7201182370, content=<a href='/topic/show?id=7d69598468' target=_blank style='color:#2F92EE;'>#Dis#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=96, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5984, encryptionId=7d69598468, topicName=Dis)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c689267, createdName=cmj8wellington, createdTime=Wed Apr 02 23:11:00 CST 2014, time=2014-04-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1656580, encodeId=56ec1656580fa, content=<a href='/topic/show?id=3ca31e71903' target=_blank style='color:#2F92EE;'>#TRA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17719, encryptionId=3ca31e71903, topicName=TRA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=757b24868428, createdName=bsmagic9140, createdTime=Sun Mar 09 21:11:00 CST 2014, time=2014-03-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2032032, encodeId=598a2032032c2, content=<a href='/topic/show?id=07c4e6558d5' target=_blank style='color:#2F92EE;'>#精神症状#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=76558, encryptionId=07c4e6558d5, topicName=精神症状)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e87531, createdName=klivis, createdTime=Sat Dec 28 19:11:00 CST 2013, time=2013-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2021463, encodeId=465e2021463bd, content=<a href='/topic/show?id=31e8e9669d' target=_blank style='color:#2F92EE;'>#GER#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7966, encryptionId=31e8e9669d, topicName=GER)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=48732500158, createdName=12498c32m68暂无昵称, createdTime=Mon Sep 23 06:11:00 CST 2013, time=2013-09-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1250386, encodeId=cb411250386a8, content=<a href='/topic/show?id=7d6f52988e1' target=_blank style='color:#2F92EE;'>#患病率#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=52988, encryptionId=7d6f52988e1, topicName=患病率)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f49517, createdName=xinmeili, createdTime=Tue Jun 11 00:11:00 CST 2013, time=2013-06-11, status=1, ipAttribution=)]

相关资讯

NEJM:痴呆花费已超过癌症和心脏病

4月3日《新英格兰医学杂志》(New England Journal of Medicine)发表的一项研究显示,2010年,美国财政支出中痴呆的花费为1,590亿~2,150亿美元,使其成为较癌症或心脏病更大的财政负担。加州圣塔莫尼卡市RAN老龄化研究中心主任Michael D. Hurd博士及其合作者使用健康和退休研究中的856例接受综合家庭临床痴呆评估的患者亚组,评估了美国的痴呆患病率和花费

NEJM:研究揭示共济失调、痴呆和低性腺功能综合征的致病基因

一例共济失调、痴呆和低性腺功能综合征患者的影像学及神经病理资料 共济失调和性腺机能减退综合征在一个世纪以前就被描述,但是其基因异常情况却不甚明了。来自哈佛生殖研究中心的David H. Margolin等教授采用外显子测序的方法揭示了共济失调、痴呆和低性腺功能综合征的致病基因,发现其与泛素化功能障碍相关,研究结果在线发表在新英格兰杂志上。 该研究采用全外显子测序的方法检测了伴有共济失调及低促性

Eur Heart J:胆碱酯酶抑制剂或降阿尔茨海默型痴呆患者的心梗危险

  瑞典一项研究表明,胆碱酯酶抑制剂(ChEI)与阿尔茨海默型痴呆患者的心肌梗死和死亡危险降低相关,这种相关性随着ChEI剂量的增加而增强。相关论文6月4日在线发表于《欧州心脏杂志》(Eur Heart J)。   该队列研究入选了7073例平均年龄在79岁的阿尔茨海默型痴呆或伴有痴呆的阿尔茨海默病患者。结果在平均随访的503天期间,831例受试者发生看MI或死亡。校正混杂因

Nat Neurosci:神经元DNA双链断裂参与痴呆的发病

长期以来,科学家认为一种特殊的DNA损伤——DNA双链断裂(DSB)对脑细胞特别有害,是老年病如老年痴呆背后的主要推手。据物理学家组织网3月24日报道,最近,美国加利福尼亚大学旧金山分校格拉斯通研究所科学家发现,DSB实际上是一种常规的、非伤害性脑活动过程的一部分。这一发现有助于理解老年痴呆症背后的机制。他们还利用小鼠模型确定了两种治疗方案,能降低老年痴呆症中过高的DSB破坏。相关论文发表在24日

Aging Cell:研究发现糖尿病与​​老年痴呆症发病相关

越来越多的证据表明,糖尿病和阿尔茨海默氏病有可能存在某种联系,但糖尿病影响大脑功能和认知的生理机制尚不完全清楚。在一项新的发表在Aging Cell杂志上研究中,索尔克生物研究所研究人员研究表明,糖尿病会加快老化发展,依据阿尔茨海默氏症早在的病理事件。 具体而言,索尔克研究小组发现阿尔茨海默病两个标志,β淀粉样蛋白和tau蛋白存在于糖尿病小鼠大脑中,尤其是在血管周围的细胞中。β淀粉样蛋白的积累被

EHJ:痴呆症药物或有助降低心血管疾病风险

日前,瑞典于默奥大学等机构一项最新研究发现,服用一类治疗早期痴呆症(阿尔茨海默氏症)的药物可能有“意外收效”,即降低心脏病发作、中风等心血管疾病的风险。相关研究论文刊登在了近期出版的《欧洲心脏病学杂志》上。 在这项最新研究中,科学家于2007年5月至2010年12月,对7073名阿尔茨海默氏症患者的医疗记录进行了研究。结果发现,服用一类名为胆碱酯酶抑制剂药物的患者,心脏病、中风等心血管疾病的发病

Baidu
map
Baidu
map
Baidu
map